| Identification of long noncoding RNA H19 as a new biomarker and therapeutic target in right ventricular failure in pulmonary arterial hypertension J Omura, K Habbout, T Shimauchi, WH Wu, S Breuils-Bonnet, E Tremblay, ... Circulation 142 (15), 1464-1484, 2020 | 114 | 2020 |
| Cardiac magnetic resonance in pulmonary hypertension—an update S Alabed, P Garg, CS Johns, F Alandejani, Y Shahin, K Dwivedi, H Zafar, ... Current Cardiovascular Imaging Reports 13, 1-9, 2020 | 18 | 2020 |
| Age-associated changes in 4D flow CMR derived tricuspid valvular flow and right ventricular blood flow kinetic energy N Barker, H Zafar, B Fidock, A Elhawaz, A Al-Mohammad, A Rothman, ... Scientific reports 10 (1), 9908, 2020 | 12 | 2020 |
| Left ventricular blood flow kinetic energy is associated with the six-minute walk test and left ventricular remodelling post valvular intervention in aortic stenosis A Elhawaz, GT Archer, H Zafar, B Fidock, N Barker, R Jones, A Rothman, ... Quantitative imaging in medicine and surgery 11 (4), 1470, 2021 | 2 | 2021 |
| Remote evaluation of risk and physiological response to therapeutic escalation and clinical worsening in patients with pulmonary hypertension JT Middleton, S Binmahfooz, H Zafar, J Patel, C Ashraf, J Taylor, ... | 1 | 2023 |
| Remote Monitoring of the Haemodynamic Response to Clinically Indicated Therapeutic Escalation and Clinical Worsening Events in Patients With Pulmonary Arterial Hypertension JT Middleton, S Binmahfooz, H Zafar, J Patel, D Giri, C Battersby, ... Circulation 146 (Suppl_1), A13553-A13553, 2022 | 1 | 2022 |
| The Development of a Remote Pulmonary Arterial Hypertension Risk Score Utilising Remote Monitoring Technology to Monitor Parameters Associated With Mortality in Pulmonary … JT Middleton, S Binmahfooz, H Zafar, J Patel, DG Neelam Naganathan, ... Circulation 146 (Suppl_1), A13527-A13527, 2022 | 1 | 2022 |
| P38 Assessing the repeatability of NT-proBNP testing using laboratory and point of care testing in PAH (REPEAT-PAH) C Durrington, C Battersby, L Holt, A Fairman, T Salisbury, H Turton, ... Thorax 77 (Suppl 1), A101-A101, 2022 | 1 | 2022 |
| 124 Comparing the safety and feasibility of implanting pulmonary artery pressure monitors via the internal jugular vein compared to standard femoral venous access in patients … J Middleton, H Zafar, DG Kiely, A Rothman Heart 107 (Suppl 1), A93-A93, 2021 | 1 | 2021 |
| 121 Effect of UK COVID-19 public health measures on activity and quality of life in patients with pulmonary arterial hypertension J Middleton, H Zafar, A Reddy, C Martin, R Thompson, A Swift, M Toshner, ... Heart 107 (Suppl 1), A91-A91, 2021 | 1 | 2021 |
| Long non-coding RNA H19 promotes right ventricular failure in PAH J Omura, K Habbout, T Shimauchi, S Breuils-Bonnet, E Tremblay, ... A93. TRANSLATIONAL RESEARCH; EARLY CLINICAL FINDINGS AND OMICS ADVENTURE IN …, 2020 | 1 | 2020 |
| An exercise-based cardiac rehabilitation programme for AF patients in the NHS: a feasibility study M Mills, E Johnson, H Zafar, A Horwood, N Lax, S Charlesworth, ... The British Journal of Cardiology 27 (2), 2020 | 1 | 2020 |
| Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose‐response and clinical efficacy … F Varian, J Dick, C Battersby, S Roman, J Ablott, L Watson, S Binmahfooz, ... Pulmonary Circulation 14 (1), e12337, 2024 | | 2024 |
| Anatomical characterization of pulmonary artery and implications to pulmonary artery pressure monitor implantation H Zafar, D Neelam-Naganathan, JT Middleton, SK Binmahfooz, ... Scientific Reports 13 (1), 20528, 2023 | | 2023 |
| 158 Remote personalisation of pulmonary arterial hypertension therapy and application of a remote physiological risk score F Varian, S Binmahfooz, R Condliffe, JT Middleton, AMK Rothman, J Patel, ... Heart 109 (Suppl 3), A186-A187, 2023 | | 2023 |
| 138 Physiological detection of clinical worsening and therapeutic response using implanted remote technologies in pah J Middleton, D Neelam-Naganathan, C Elliot, J Taylor, M Toshner, H Zafar, ... Heart 109 (Suppl 3), A159-A161, 2023 | | 2023 |
| BS74 Assessment of fluid status in porcine models of heart failure and pulmonary hypertension H Zafar, J Passman, R Sandy, C Wright, F Wright, H Evans, L Ebah, ... Heart 109 (Suppl 3), A298-A300, 2023 | | 2023 |
| 137 Design and validation of a physiological risk score for pulmonary arterial hypertension (pah) J Middleton, C Elliot, C Pearson, C Battersby, S Roman, I Armstrong, ... Heart 109 (Suppl 3), A156-A159, 2023 | | 2023 |
| 154 Stability of daily physical activity as a remote measure of clinical risk in pulmonary arterial hypertension (pah) C Ashraf, J Taylor, C Roddis, M Toshner, JT Middleton, J Hurdman, ... Heart 109 (Suppl 3), A181-A182, 2023 | | 2023 |
| 153 Differences in physical activity, heart rate and heart variability during clinical worsening events in patients with pulmonary arterial hypertension (pah) J Taylor, DG Kiely, N Hamilton, J Hurdman, K Dwivedi, C Pearson, ... Heart 109 (Suppl 3), A179-A181, 2023 | | 2023 |
David G KielyConsultant Respiratory Physician and Director Sheffield Pulmonary Vascular Disease UnitVerified email at sth.nhs.uk
